Clinical Hematology and Hemato-Oncology: Diagnosis, Management, and Advances

Hereditary & Acquired Anemias Including of Nutritional Causes

1. Vitamin B12 and Folic Acid: Biochemistry, and Burden of Disease in India — pp. 3–19
2. Iron Metabolism and Inherited Causes of Iron Deficiency Anemia — pp. 21–43
3. Iron Deficiency Anemia: Newer Iron Formulations and Their Advantages — pp. 45–58
4. Diagnostic Approach to Non-spherocytic Haemolytic Anaemia (NSHA) — pp. 59–77
5. Management of Anemia of Renal Failure — pp. 79–100
6. Management of Aplastic Anemia — pp. 101–113
7. Comprehensive Management of Thalassemic Patients Including Pregnancy — pp. 115–138
8. Comprehensive Management of Sickle Cell Disorders — pp. 139–157

Advanced Cutting-Edge Technology in Hematology

9. Gene Therapy for Hemoglobinopathy Current Status and Future Direction — pp. 161–176
10. Role of Flow Cytometry in the Diagnosis of Benign Haematological Disorders — pp. 177–200
11. Molecular Genetic Tests in Thalassemias and the Hemoglobinopathies: Pros and Cons of Different Techniques — pp. 201–223
12. Prenatal Diagnosis for Hereditary Haematologic Disorders — pp. 225–251
13. NGS for Precision Medicine in Hematologic Disorders — pp. 253–272
14. Cytogenetics and FISH in Hematologic Malignancies — pp. 273–289
15. Measurable Residual Disease (MRD) in Haematological Malignancies: A Comparative Overview of Flow Cytometry, Molecular, and Next-Generation Sequencing Approaches — pp. 291–313

Hemostasis & Thrombosis

16. Spectrum of Coagulation Factor Deficiencies and the Approach to Diagnosis — pp. 317–335
17. Laboratory Monitoring of Newer Anticoagulants and Fondaparinux — pp. 337–350
18. Management of ITP: Including Approach in Refractory Patients in Children and Adults — pp. 351–372
19. Comprehensive Management of Hemophilia, Including Recent Therapeutic Advances — pp. 373–397
20. Point-of-Care Testing in Diagnosis and Management of Haemostatic Disorders — pp. 399–417
21. Advances in the Diagnosis of DIC and Fibrinolysis — pp. 419–437
22. Thrombophilia: Their Relevance in Arterial and Venous Thrombosis — pp. 439–457
23. Diagnosis of Antiphospholipid Syndrome and Role in Different Clinical Conditions — pp. 459–480
24. Diagnosis of Thrombotic Thrombocytopenic Purpura and Current Management — pp. 481–500

Myeloma & Lymphoid Malignancies

25. Liquid/Fluid Biopsy and Its Role in Lymphomas — pp. 503–518
26. Flow Cytometric Diagnostic Approach to Low-Grade Lymphomas — pp. 519–536
27. Risk Stratification and Advances in CLL Management. How to Choose Best BTK Inhibitor for CLL Patient? — pp. 537–551
28. Management of Aggressive Non-Hodgkins Lymphoma: Case-Based Approach — pp. 553–564
29. MGUS and Its Clinical Variants — pp. 565–585
30. Multiple Myeloma: Risk Stratification and Management — pp. 587–604

Myeloid Malignancies

31. Who-HEM5 and ICC(2022) Classifications for Myeloid Neoplasms — pp. 607–630
32. Risk Stratification and Updates in Management of MDS — pp. 631–652
33. Management of Chronic Myeloid Leukemia in Adults and Children — pp. 653–673
34. NonBCR: ABL MPN: Diagnosis, Risk Stratification, and Management — pp. 675–706
35. Recent Advances in Management of Acute Myeloid Leukaemia — pp. 707–723
36. Management of Elderly AML — pp. 725–740
37. Venetoclax: A Magic Drug for Hematological Malignancies — pp. 741–761
38. CAR-T Cell Therapy in Haematologic Malignancies — pp. 763–781

Hematopoietic Stem Cell Transplant

39. Present Status of Stem Cell Transplant in Acute Leukemia in Children and Adults — pp. 785–798
40. Management of Acute and Chronic GVHD: Current Status and Recent Advances — pp. 799–833
41. The Role of Allogeneic Stem Cell Transplantation in Philadelphia Positive Acute Lymphoblastic Leukemia in the Era of Second- and Third-Generation TKI — pp. 835–851
42. Conditioning Regimen for Hematopoietic Stem Cell Transplant — pp. 853–879
43. Haploidentical Hematopoietic Stem Cell Transplantation — pp. 881–900

CBC in Infection & Blood Component Therapy

44. Automated Hemogram Analyzer Parameters in Diagnosis of Sepsis/Infections — pp. 903–922
45. Blood Component Therapy in Hematological Patients — pp. 923–952